Triple-negative breast cancer (TNBC), characterized by lack of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) amplification, represents the most aggressive subtype of breast cancers [1–3]. This evidence concerns the gene PGR and breast carcinoma.